Suppose Pheasant Pharmaceuticals is evaluating a proposed capital budgeting project (project Beta) that will require an initial investment of $2,750,000. The project is expected to generate the following net cash flows: Year Year 1 Year 2 Cash Flow $350,000 $500,000 $425,000 $425,000 Year 3 Year 4 Pheasant Pharmaceuticals's weighted average cost of capital is 10%, and project Beta has the same risk as the firm's average project. Based on the cash flows, what is project Beta's NPV? -$1,409,006 -$1,059,006 0 $1,690,807 -3984,006